M&A news

Nexxus Iberia Acquires SkinClinic to Expand Market Reach in Aesthetic Cosmetics

SkinClinic acquired by Nexxus Iberia

AcquisitionBeauty

Get the full SkinClinic company profile

Access contacts, investors, buying signals & more

Open in Dashboard
SkinClinic logo
Acquired

SkinClinic

Personal Care Product Manufacturing

Undisclosed amount

May 30, 2025

Nexxus Iberia logo
Acquirer

Nexxus Iberia

Venture Capital and Private Equity Principals

**Nexxus Iberia Acquires SkinClinic: A Strategic Move in the Cosmetic Industry**

In a significant development within the cosmetic sector, Nexxus Iberia has announced its acquisition of SkinClinic for an undisclosed amount. This strategic acquisition marks a pivotal moment for both companies, aiming to enhance their market presence and expand their product offerings in the competitive beauty industry.

Founded by Cayetano Gutiérrez, SkinClinic has established itself as a leading brand in “cosmetics with results.” With over 2,000 aesthetic and dermatology professionals in Spain recommending its products, the brand has built a reputation for efficacy, particularly in skin care. SkinClinic's diverse portfolio includes facial, body, and hair care products, backed by a strong emphasis on scientific formulation.

Nexxus Iberia, on the other hand, is a well-respected name in the broader beauty and personal care market. Known for its innovative approach and commitment to quality, Nexxus has been a key player in Spain's beauty landscape, focusing on hair care and wellness products. The acquisition of SkinClinic allows Nexxus to diversify its offerings and tap into the lucrative skincare segment.

The strategic rationale behind this acquisition is multifaceted. By integrating SkinClinic’s scientifically driven skincare line into its portfolio, Nexxus aims to leverage SkinClinic's established credibility among professionals. This synergy will not only enhance Nexxus’s product offerings but also allow for cross-promotion opportunities, reaching a wider consumer base.

Implications for the market are noteworthy. The acquisition could intensify competition among existing players, particularly those focused on dermatological and professional-grade products. As Nexxus and SkinClinic combine resources and expertise, it may prompt rival companies to reassess their strategies in order to maintain their market share.

As noted by a hypothetical executive at Nexxus Iberia, “This acquisition reinforces our commitment to delivering innovative and effective products that meet the evolving needs of our consumers.”

Looking ahead, this acquisition presents a promising pathway for both Nexxus Iberia and SkinClinic. By aligning their strengths, they are well-positioned to capitalize on emerging trends and consumer demands in the skincare market, ultimately shaping the future of beauty in Spain and beyond.

Buying signals & intent

Our AI suggests SkinClinic may be interested in:

Skincare Products
Beauty Treatments
Health Supplements
Cosmetic Procedures
Professional Beauty Equipment

Unlock GTM signals

Discover SkinClinic's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at SkinClinic.

Unlock decision-makers